Anatomical location and redistribution of G protein-coupled estrogen receptor-1 during the estrus cycle in mouse kidney and specific binding to estrogens but not aldosterone

Molecular and Cellular Endocrinology

Volumn 382, Issue 2, 2014, Pages 950-959

  Cheng, Shi Bin ^a   Dong, Jing ^c   Pang, Yefei ^c   LaRocca, Jessica ^b   Hixon, Mary ^b   Thomas, Peter ^c   Filardo, Edward J ^a  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Aldosterone binding; Distal convoluted tubules; Estradiol binding; Estrus cycle; GPER 1; Mineralocorticoid receptor

Indexed keywords

ALDOSTERONE; ESTRADIOL; ESTROGEN; G PROTEIN COUPLED RECEPTOR 30; GUANINE NUCLEOTIDE BINDING PROTEIN; MEGALIN; MINERALOCORTICOID RECEPTOR; RECOMBINANT G PROTEIN COUPLED RECEPTOR 30; RECOMBINANT PROTEIN; TAMM HORSFALL PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO; ESTRUS CYCLE; FEMALE; HENLE LOOP; HUMAN; HUMAN CELL; KIDNEY; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; KIDNEY EPITHELIUM; LUTEAL PHASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROESTRUS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; SECRETORY PHASE; SIGNAL TRANSDUCTION; UPREGULATION;

ALDOSTERONE BINDING; DISTAL CONVOLUTED TUBULES; ESTRADIOL BINDING; ESTRUS CYCLE; GPER-1; MINERALOCORTICOID RECEPTOR;

ALDOSTERONE; ANIMALS; ESTRADIOL; ESTRUS; FEMALE; GENE EXPRESSION REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HEK293 CELLS; HUMANS; KIDNEY TUBULES, DISTAL; LOOP OF HENLE; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-2; MICE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PROTEIN BINDING; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, MINERALOCORTICOID; REPRODUCTION; SPIRONOLACTONE;

EID: 84890247057     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.11.005     Document Type: Article

References (63)

1. Barton M. Position paper: the membrane estrogen receptor GPER-Clues and questions. Steroids 2012, 77:935-942.
2. Batenburg W.W., Jansen P.M., van den Bogaerdt A.J., Ah J.D. Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase. Cardiovasc. Res. 2012, 94:136-143.
3. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., Parker M.A., Tkachenko S.E., Savchuc N.P., Sklar L.A., Oprea T.I., Prossnitz E.R. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2006, 2:207-212.
4. Carroll J.C., Rosario E.R. The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease. Curr. Alzheimer Res. 2012, 9:18-34.
5. Cheng S.B., Graeber C.T., Quinn J.A., Filardo E.J. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 GPR30/GPER. from the plasma membrane towards the nucleus. Steroids 2011, 76:892-896.
6. Cheng S.B., Quinn J.A., Graeber C.T., Filardo E.J. Down-modulation of the G-protein-coupled estrogen receptor, GPER, from the cell surface occurs via a trans-Golgi-proteasome pathway. J. Biol. Chem. 2011, 286:22441-22455.
7. Christy N.P., Shaver J.C. Estrogens and the kidney. Kidney Int. 1974, 6:366-376.
8. De Marco P., Bartella V., Vivacqua A., Lappano R., Santolla M.F., Morcavallo A., Pezzi V., Belfiore A., Maggiolini M. Insulin-like growth factor-I regulates GPER expression and function in cancer cells. Oncogene 2013, 32(6):678-688.
9. Dennis M.K., Burai R., Ramesh C., Petrie W.K., Alcon S.N., Nayak T.K., Bologa C.G., Leitao A., Brailoiu E., Deliu E., Dun N.J., Sklar L.A., Hathaway H.J., Arterburn J.B., Oprea T.I., Prossnitz E.R. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol. 2009, 5:421-427.
10. Feldman R.D., Gros R. Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways. Br. J. Pharmacol. 2011, 163:1163-1169.
11. Filardo E.J., Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol. Metab. 2005, 16:362-367.
12. Filardo E.J., Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 2012, 153:2953-2962.
13. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
14. Filardo E.J., Quinn J.A., Frackelton A.R., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 2002, 16:70-84.
15. Filardo E., Quinn J., Pang Y., Graeber C., Shaw S., Dong J., Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 GPR30. at the plasma membrane. Endocrinology 2007, 148:3236-3245.
16. Fiorelli A., Ricciardi C., Pannone G., Santoro A., Bufo P., Santini M., Serpico R., Rullo R., Pierantoni G.M., Di Domenico M. Interplay between steroid receptors and neoplastic progression in sarcoma tumors. J. Cell. Physiol. 2011, 226:2997-3003.
17. Funakoshi T., Yanai A., Shinoda K., Kawano M.M., Mizukami Y. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem. Biophys. Res. Commun. 2006, 346:904-910.
18. Funder J.W. GPR30, mineralocorticoid receptors, and the rapid vascular effects of aldosterone. Hypertension 2011, 57:370-372.
19. Gennari L., Merlotti D., Valleggi F., Martini G., Nuti R. Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development. Drugs Aging 2007, 24:361-379.
20. Grimont A., Bloch-Faure M., El Abida B., Crambert G. Mapping of sex hormone receptors and their modulators along the nephron of male and female mice. FEBS Lett. 2009, 583:1644-1648.
21. Grodstein F., Manson J.E., Colditz G.A., Willett W.C., Speizer F.E., Stampfer M.J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann. Intern. Med. 2000, 133:933-941.
22. Gros R., Ding Q., Sklar L.A., Prossnitz E.E., Arterburn J.B., Chorazyczewski J., Feldman R.D. GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone. Hypertension 2011, 57:442-451.
23. Gros R., Ding Q., Liu B., Chorazyczewski J., Feldman R.D. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am. J. Physiol. Cell Physiol. 2013, 304(6). C532-40.
24. Grossman C., Benesic A., Krug A.W., Freudinger R., Mildenberger S., Gassner B., Gekle M. Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions. Mol. Endoc. 2005, 19:1697-1710.
25. Hazell G.G., Yao S.T., Roper J.A., Prossnitz E.R., O'Carroll A.M., Lolait S.J. Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J. Endocrinol. 2009, 202:223-236.
26. Hewitt S.C., Harrell J.C., Korach K.S. Lessons in estrogen biology from knockout and transgenic animals. Ann. Rev. Physiol. 2005, 67:285-308.
27. Hofmeister M.V., Damkier H.H., Christensen B.M., Olde B., Fredrik Leeb-Lundberg L.M., Fenton R.A., Praetorius H.A., Praetorius J. 17beta-Estradiol induces nongenomic effects in renal intercalated cells through G protein-coupled estrogen receptor 1. Am J Physiol Renal Physiol 2012, 302:F358-F368.
28. Holm A., Baldetorp B., Olde B., Leeb-Lundberg L.M., Nilsson B.O. The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle. J. Vasc. Res. 2011, 48:327-335.
29. Hsieh Y.C., Yu H.P., Frink M., Suzuki T., Choudhry M.A., Schwacha M.G., Chaudry I.H. G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage. Am. J. Pathol. 2007, 170:1210-1218.
30. Hutchens M.P., Nakano T., Kosaka Y., Dunlap J., Zhang W., Herson P.S., Murphy S.J., Anderson S., Hurn P.D. Estrogen is renoprotective via a nonreceptor-dependent mechanism after cardiac arrest in vivo. Anesthesiology 2010, 112:395-405.
31. Hutchens M.P., Fujiyoshi T., Komers R., Herson P.S., Anderson S. Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo. Am. J. Physiol. Renal. Physiol. 2012, 303:F377-F385.
32. Kelder J., Azevedo R., Pang Y., de Vlieg J., Dong J., Thomas P. Comparison between steroid binding to membrane progesterone receptor alpha mPRalpha. and to nuclear progesterone receptor: correlation with physicochemical properties assessed by comparative molecular field analysis and identification of mPRalpha-specific agonists. Steroids 2010, 75:314-322.
33. Korach K.S. Estrogen receptor knock-out mice: molecular and endocrine phenotypes. J. Soc. Gynecol. Investig. 2000, 7:S16-S17.
34. Krug A.W., Pojoga L.H., Williams G.H., Adler G.K. Cell membrane-associated mineralocorticoid receptors? New evidence. Hypertension 2011, 57:1019-1025.
35. Lindsey S.H., Yamaleyeva L.M., Brosnihan K.B., Gallagher P.E., Chappell M.C. Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. Hypertension 2011, 58:665-671.
36. Liu S.B., Han J., Zhang N., Tian Z., Li X.B., Zhao M.G. Neuroprotective effects of oestrogen against oxidative toxicity through activation of G-protein-coupled receptor 30 receptor. Clin. Exp. Pharmacol. Physiol. 2011, 38:577-585.
37. Liu S.B., Zhang N., Guo Y.Y., Zhao R., Shi T.Y., Feng S.F., Wang S.Q., Yang Q., Li X.Q., Wu Y.M., Ma L., Hou Y., Xiong L.Z., Zhang W., Zhao M.G. G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J. Neurosci. 2012, 32:4887-4900.
38. Marchese A., Paing M.M., Temple B.R., Trejo J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmacol. Toxicol. 2008, 48:601-629.
39. Martensson U.E., Salehi S.A., Windahl S., Gomez M.F., Sward K., Daszkiewicz-Nilsson J., Wendt A., Andersson N., Hellstrand P., Grande P.O., Owman C., Rosen C.J., Adamo M.L., Lundquist I., Rorsman P., Nilsson B.O., Ohlsson C., Olde B., Leeb-Lundberg L.M. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 2009, 150:687-698.
40. Meyer M.R., Prossnitz E.R., Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul. Pharmacol. 2011, 55:17-25.
41. Moyer B., Hixon M.L. Reproductive effects in F1 adult females exposed in utero to moderate to high doses of mono-2-ethylhexylphthalate MEHP. Reprod. Toxicol. 2012, 34:43-50.
42. Nelson H.D., Rizzo J., Harris E., Cauley J., Ensrud K., Bauer D.C., Orwoll E. Osteoporosis and fractures in postmenopausal women using estrogen. Arch. Intern. Med. 2002, 162:2278-2284.
43. Osanai, T., Yamada, M., Okumura, K., 2011. Nongenomic response to aldosterone. Hypertension 58, e3; author reply e4.
44. Pang Y., Thomas P. Progesterone signals through membrane progesterone receptors mPRs. in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor. Steroids 2011, 76:921-928.
45. Pang Y., Dong J., Thomas P. Estrogen signaling characteristics of Atlantic croaker G protein-coupled receptor 30 GPR30. and evidence it is involved in maintenance of oocyte meiotic arrest. Endocrinology 2008, 149:3410-3426.
46. Peyton C., Thomas P. Involvement of epidermal growth factor receptor signaling in estrogen inhibition of oocyte maturation mediated through the G protein-coupled estrogen receptor Gper. in zebrafish Danio rerio. Biol. Reprod. 2011, 85:42-50.
47. Quinn J.A., Graeber C.T., Frackelton A.R., Kim M., Schwarzbauer J.E., Filardo E.J. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein-coupled receptor, GPR30. Mol. Endocrinol. 2009, 23:1052-1064.
48. Ren J., Wu J.H. 17beta-estradiol rapidly activates calcium release from intracellular stores via the GPR30 pathway and MAPK phosphorylation in osteocyte-like MLO-Y4 cells. Calcif. Tissue Int. 2012, 90:411-419.
49. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
50. Ropero A.B., Pang Y., Alonso-Magdalena P., Thomas P., Nadal A. Role of ERbeta and GPR30 in the endocrine pancreas: a matter of estrogen dose. Steroids 2012, 77:951-958.
51. Sandén C., Broselid S., Cornmark L., Andersson K., Daszkiewicz-Nilsson J., Mårtensson U.E., Olde B., Leeb-Lundberg L.M. G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol. Pharmacol. 2011, 79:400-410.
52. Spary E.J., Chapman S.E., Sinfield J.K., Maqbool A., Kaye J., Batten T.F. Novel G protein-coupled oestrogen receptor GPR30 shows changes in mRNA expression in the rat brain over the oestrous cycle. Neurosignals 2013, 21:14-27.
53. Terasawa E., Kenealy B.P. Neuroestrogen, rapid action of estradiol, and GnRH neurons. Front Neuroendocrinol. 2012, 33(4):364-375.
54. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
55. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
56. Thomas P., Alyea R., Pang Y., Peyton C., Dong J., Berg A.H. Conserved estrogen binding and signaling functions of the G protein-coupled estrogen receptor 1 GPER1 in mammals and fish. Steroids 2010, 75:595-602.
57. Tomaschitz A., Pilz S., Ritz E., Obermayer-Pietsch B., Pieber T.R. Aldosterone and arterial hypertension. Nat. Rev. Endocrinol. 2010, 6:83-93.
58. Vogelvang T.E., van der Mooren M.J., Mijatovic V., Kenemans P. Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women. Drugs 2006, 66:191-221.
59. Wang C., Prossnitz E.R., Roy S.K. Expression of G protein-coupled receptor 30 in the hamster ovary: differential regulation by gonadotropins and steroid hormones. Endocrinology 2007, 148:4853-4864.
60. Wang C., Dehghani B., Magrisso I.J., Rick E.A., Bonhomme E., Cody D.B., Elenich L.A., Subramanian S., Murphy S.J., Kelly M.J., Rosenbaum J.S., Vandenbark A.A., Offner H. GPR30 contributes to estrogen-induced thymic atrophy. Mol. Endocrinol. 2008, 22:636-648.
61. Wendler, A., Wehling, M., 2011. Is GPR30 the membrane aldosterone receptor postulated 20 years ago? Hypertension 57, e16; author reply e17.
62. Wildling L., Hinterdorfer P., Kusche-Vihrog K., Treffner Y., Oberleithner H. Aldosterone receptor sites on plasma membrane of human vascular endothelium detected by a mechanical nanosensor. Pflug. Arch. 2009, 458:223-230.
63. Wise P.M. Estrogens and cerebrovascular stroke: what do animal models teach us?. Ann. NY Acad. Sci. 2005, 1052:225-232.